Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research ...

Iovance Biotherapeutics Inc (IOVA) stock saw a decline, ending the day at $6.19 which represents a decrease of $-0.06 or -0.96% from the prior close of $6.25. The stock opened at $6.28 and touched a ...

Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that ...

Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $6.25 which represents a slight increase of $0.06 or 0.97% from the prior close of $6.19. The stock opened at $6.24 and ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Iovance Biotherapeutics (IOVA – Research Report) and ...

If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...

Technical analysis for Iovance Biotherapeutics Inc. IOVA including support levels resistance levels and stop losses for IOVA ...

We recently published a list of Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks. In this article, we are going to ...

Investors seem to be underestimating all of it. It's been a tough past four years for Iovance Biotherapeutics(NASDAQ: IOVA) ...